Korea Investment CORP Sells 20,500 Shares of DaVita Inc. $DVA

Key Points

• Korea Investment CORP significantly reduced its holdings in DaVita Inc. by 81.9%, selling 20,500 shares in the first quarter, leaving it with a total of 4,519 shares valued at approximately $691,000.
• In contrast, other hedge funds increased their stakes in DaVita, with GAMMA Investing LLC raising its holdings by an astonishing 14,695.8%, now owning 234,809 shares worth nearly $35.9 million.
• DaVita's latest earnings report showed a net income per share of $2.95, surpassing analyst expectations, and the company has set a fiscal year 2025 earnings guidance of $10.200-11.300 EPS.

Korea Investment CORP lessened its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 81.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,519 shares of the company's stock after selling 20,500 shares during the quarter. Korea Investment CORP's holdings in DaVita were worth $691,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Invesco Ltd. grew its holdings in DaVita by 3.4% during the 1st quarter. Invesco Ltd. now owns 1,642,947 shares of the company's stock valued at $251,322,000 after buying an additional 53,402 shares in the last quarter. Northern Trust Corp increased its holdings in shares of DaVita by 20.2% in the first quarter. Northern Trust Corp now owns 890,632 shares of the company's stock worth $136,240,000 after purchasing an additional 149,858 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of DaVita by 14.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock worth $69,697,000 after purchasing an additional 57,386 shares during the period. Deutsche Bank AG increased its holdings in shares of DaVita by 35.2% in the fourth quarter. Deutsche Bank AG now owns 392,422 shares of the company's stock worth $58,687,000 after purchasing an additional 102,230 shares during the period. Finally, Iron Triangle Partners LP bought a new position in shares of DaVita in the fourth quarter worth $38,946,000. Hedge funds and other institutional investors own 90.12% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on DVA. Barclays decreased their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Finally, Truist Financial set a $148.00 price objective on shares of DaVita in a report on Friday, August 8th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, DaVita has an average rating of "Hold" and an average target price of $164.00.

Insiders Place Their Bets

In related news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.50% of the stock is currently owned by company insiders.

DaVita Trading Down 1.3%

NYSE:DVA traded down $1.82 during trading hours on Thursday, hitting $135.74. The company had a trading volume of 465,798 shares, compared to its average volume of 854,948. The company has a market capitalization of $9.71 billion, a PE ratio of 13.35, a price-to-earnings-growth ratio of 0.99 and a beta of 1.09. The stock has a 50-day moving average price of $139.70 and a 200 day moving average price of $143.37. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.